Coding Ahead
CasePilot
Medical Coding Assistant
CaseConsultant
Instant Email Coding Consultant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Quick Reference

  • Code definition: CPT 88305 reports Level IV surgical pathology, covering both gross (visual) and microscopic examination of a defined list of specimen types — the most frequently billed surgical pathology level in clinical practice.
  • Key billing rule: Each separately submitted, distinctly labeled specimen container equals one unit. MUE is 16 units per date of service [1].
  • Modifier essentials: Append -26 when billing the professional component only (pathologist does not own the lab); -TC for the technical component alone; no modifier when billing globally as an independent lab owner. Append -59 or -XS on additional same-date units when payer edits fire.
  • Documentation must-have: Every pathology report must include a distinct gross description and microscopic description signed by the responsible pathologist for each separately labeled specimen. A missing pathologist signature alone triggers denial of the professional component.
  • Top confusion point: Level selection is specimen-type driven, not diagnosis driven. A colon polyp revealing adenocarcinoma remains at 88305, not 88307. Upcoding based on the pathological finding is the most cited OIG audit finding in anatomic pathology [2].
  • Payer alert (OPPS): In the hospital outpatient setting, APC status for 88305 is STV-Packaged — the technical component is typically bundled into the facility's APC payment. The pathologist's professional component (-26) remains separately payable under the Physician Fee Schedule [1].
  • CLIA: Performing laboratories must hold a CLIA Certificate of Compliance or Accreditation for high-complexity testing to bill this code [3].

When to Use This Code

Clinical Indications

88305 applies when a pathologist performs both gross and microscopic examination on a specimen type that appears on the AMA CPT Level IV specimen list. The list is extensive: colorectal polyps, colon biopsies, prostate needle biopsies, cervical and endometrial biopsies, skin biopsies (excluding simple cysts, tags, and debridement), lymph node biopsies, kidney biopsies, bronchial biopsies, endocervical and endometrial curettings, spontaneous abortions, breast biopsies not requiring margin evaluation, fallopian tube ectopic pregnancies, and many others [4].

The common thread is moderate clinical complexity — specimens requiring both a gross description and cellular-level microscopic evaluation, submitted from anatomic sites where pathological findings directly inform surgical or medical management.

Scope Boundaries

Use 88305 only when the specimen type appears on the current AMA CPT Level IV specimen list. Specimens on adjacent levels are not interchangeable:

  • Breast excision requiring microscopic evaluation of surgical margins escalates to Level V (88307), while a breast biopsy not requiring margin evaluation stays at 88305
  • Prostate TUR (transurethral resection) is on the 88305 list, distinct from radical prostatectomy which belongs at 88307 or 88309
  • Verify gallbladder placement against the current AMA CPT edition each year — specimen list assignments shift between annual editions

Do not assign 88305 based on complexity of the pathological diagnosis or time spent reviewing slides. The AMA CPT specimen list is prescriptive [4].

Mohs surgery exclusion: CPT guidelines explicitly state that 8830288309 must not be reported on the same specimen as part of Mohs micrographic surgery (1731117315). Separate pathology codes for Mohs tissue are not appropriate [4].

Provider and Setting Context

88305 is billable by pathologists in any setting: private labs, hospital outpatient, and academic medical centers. The critical billing distinction is ownership of the technical component:

  • Hospital-employed or contracted pathologist: bill -26; the hospital bills -TC (subject to OPPS packaging rules in outpatient)
  • Independent pathologist who owns the lab: bill globally (no modifier)
  • Reference lab arrangement: the reference lab performing the TC bills -TC or globally; the reviewing pathologist who signs the report bills -26

Code Differentiation Table

Code Description When to Use Instead
88305 Level IV, gross and microscopic Specimen type appears on the Level IV AMA CPT list (e.g., colon biopsy, prostate needle biopsy, cervical biopsy, skin biopsy)
88300 Level I, gross exam only Specimen requires gross examination only with no microscopic component (e.g., calculus, foreign body, teeth)
88302 Level II, gross and microscopic Specimen is on the Level II list — typically expected to be normal (e.g., appendix incidental, fallopian tube for sterilization, hernia sac)
88304 Level III, gross and microscopic Specimen is on the Level III list (e.g., gallbladder, skin cyst or tag, induced abortion, abscess)
88307 Level V, gross and microscopic Specimen is on the Level V list — complex neoplastic resections requiring margin assessment (e.g., breast excision with margins, thyroid, partial nephrectomy)
88309 Level VI, gross and microscopic Specimen is on the Level VI list — most complex total organ resections (e.g., colon resection for tumor, radical prostatectomy, lung lobectomy for tumor)

The critical rule: use the AMA CPT codebook's Level IV specimen list as the governing document. When the specimen type does not appear on any list, select the level that most accurately reflects the examination complexity and document the rationale. Level escalation based on diagnosis without a corresponding specimen list match is the central compliance failure in anatomic pathology audits [2].

flowchart TD
    A[Specimen received for surgical pathology] --> B{Gross exam only?}
    B -- Yes --> C[88300 Level I]
    B -- No --> D{Match specimen type to AMA CPT list}
    D --> E{Level II list?}
    E -- Yes --> F[88302]
    E -- No --> G{Level III list?}
    G -- Yes --> H[88304]
    G -- No --> I{Level IV list?}
    I -- Yes --> J[88305]
    I -- No --> K{Level V list?}
    K -- Yes --> L[88307]
    K -- No --> M{Level VI list?}
    M -- Yes --> N[88309]
    M -- No --> O[Select closest level; document rationale]

Billing and Modifier Rules

Modifier 26 and TC

PC/TC Indicator 1 designates 88305 as a split-billable diagnostic service, applying the same component split logic used for diagnostic radiology [1].

Billing Situation Correct Modifier Who Bills
Pathologist employed by hospital, does not own lab -26 Pathologist or group
Hospital outpatient lab (technical component only) -TC Facility (OPPS packaging rules apply)
Independent pathologist who owns the lab None (global) Pathologist or group
Reference lab performing technical component only -TC Reference lab

A common error: hospital-employed pathologists billing globally (no modifier) while the hospital simultaneously bills -TC. This creates duplicate payment for the technical component.

Unit Counting

Each separately submitted, distinctly labeled specimen container equals one unit of 88305. MUE is 16 units per date of service [1].

  • 12 prostate cores submitted in 12 individual containers = 12 units
  • Biopsies from three colon segments in three separate containers = 3 units
  • Two specimens in the same container without gross differentiation = 1 unit
  • Claims exceeding 16 units require medical review documentation

When billing multiple units on the same date, append -59 (distinct procedural service) or -XS (separate structure or specimen) on units 2 and above if payer edits fire. -XS is preferable where the payer supports it, as it specifically identifies a separate specimen.

Add-On Codes

Three add-on codes pair directly with 88305 [4]:

Add-On Description When to Use
0753T Digitization of glass microscope slides for Level IV surgical pathology When slides are digitized for whole slide imaging; list separately with 88305
88311 Decalcification procedure When decalcification is required for bony specimens (e.g., bone marrow biopsy, bone exostosis); list separately
88314 Special stain, histochemical on frozen tissue block When histochemical staining is performed on frozen tissue; list separately

Separately Billable Ancillary Services

The following are not bundled with 88305 and are separately reportable when medically necessary:

  • 88312 and 88313: Special stains (Group I and II) on permanent sections
  • 88342, 88341, and 88344: Immunohistochemistry, per specimen and additional antibodies
  • 88331 and 88332: Intraoperative frozen section consultation (distinct service from the subsequent permanent section billed as 88305)
  • Routine H&E (hematoxylin and eosin) staining is included in 88305 — do not bill separately

Documentation Essentials

Required Report Elements

The pathology report supporting 88305 must contain:

  • Patient identification matching the specimen requisition exactly
  • Date of receipt and date of final report
  • Clinical history and ordering provider identification
  • Gross description for each specimen: dimensions, weight, color, texture, and characteristics of any grossly visible lesions
  • Microscopic description: histologic findings at the cellular level
  • Final diagnosis: the pathologist's interpretive conclusion for each specimen
  • Pathologist signature: the interpreting pathologist's name, credentials, and authenticating signature
  • For multiple specimens: each labeled distinctly (A, B, C...) with separate gross and microscopic descriptions and separate final diagnoses

Audit Red Flags

Auditors flag 88305 claims in these specific patterns:

  • Level escalation without specimen list support: Billing 88307 when the specimen type belongs to the 88305 list, regardless of the diagnosis found. OIG audit reviews of anatomic pathology specifically target this pattern [2].
  • Units without container documentation: Billing multiple units without corresponding laboratory accession records showing distinct specimen containers received. The lab requisition and accession log must support the unit count billed.
  • Professional component without pathologist signature: A stamped, pre-printed, or technician-authored report without an interpreting pathologist's authenticating signature does not support -26 billing.
  • Global billing by non-lab-owning pathologists: Hospital-employed pathologists billing 88305 without a modifier when they do not own the technical component.
  • Mohs surgery same-specimen billing: Reporting 88305 for tissue analyzed as part of Mohs micrographic surgery on the same specimen [4].

Medical Necessity

Surgical pathology is considered medically necessary as a routine component of standard-of-care surgical specimen evaluation. No specific NCD governs 88305. MAC-level LCDs for anatomic pathology exist in some jurisdictions and address specimen counting, level selection documentation, and CLIA compliance. Search current MAC LCDs by jurisdiction for applicable billing articles [5].

Medicare, Commercial and Medicaid Payer Rules

Medicare

OPPS (facility billing): APC status is STV-Packaged, meaning the technical component is bundled into the facility's APC payment for the triggering surgical or diagnostic procedure in the hospital outpatient setting. Do not bill -TC to Medicare Part B from a hospital outpatient department expecting separate reimbursement [1].

Physician Fee Schedule: The professional component (-26) is separately payable under the MPFS and is not affected by OPPS packaging. This is the standard billing model for hospital-based pathologists.

MUE: 16 units per date of service [1]. Claims exceeding 16 units require documentation supporting the unusual quantity.

CLIA: Medicare will not pay for 88305 from a laboratory that does not hold a valid CLIA Certificate of Compliance or Accreditation for high-complexity testing. The CLIA certificate number must appear on the claim [3].

Global period XXX: No surgical global period applies. 88305 is not bundled into any surgeon's global package and is always separately reportable.

Commercial Payers

Most commercial payers follow Medicare-parallel rules for surgical pathology level selection and PC/TC split billing. Notable differences:

  • Some payers do not recognize HCPCS modifier -XS as distinct from -59; use -59 when -XS is not supported
  • Commercial contracts with independent labs may include per-specimen pathology carve-outs; verify contract terms before applying global billing
  • Prior authorization is rarely required for 88305 itself, but may be triggered by the volume of ancillary stains (IHC, special stains) ordered alongside high-volume specimen encounters

Medicaid

Coverage and payment for 88305 vary by state. Managed Medicaid plans may impose prior authorization requirements for high-volume pathology submissions (e.g., GI endoscopy labs submitting large numbers of colon biopsy specimens per day). Verify with the applicable state Medicaid program or managed Medicaid plan before submitting.

Common Denials and Prevention

Denial: Incorrect level assigned (downcoded on audit) A payer or RAC auditor assigns 88304 or lower after reviewing the pathology report and comparing the specimen type against the AMA CPT specimen list. Prevention: Verify the specimen type against the current AMA CPT Level IV specimen list before submitting. Maintain an updated specimen-to-level reference for billing staff. Do not rely on the diagnosis to justify the level [4].

Denial: Multiple units bundled as duplicate claims Payer edits bundle multiple units of 88305 on the same date into a single unit, treating them as duplicate services rather than distinct specimens. Prevention: Append -59 or -XS to units 2 and above. Retain laboratory accession records documenting each container received, labeled, and processed separately. Include specimen identifiers in claim remarks when the payer permits.

Denial: Missing or insufficient documentation for professional component A -26 claim is denied because the pathology report lacks an authenticating pathologist signature or the microscopic description is absent. Prevention: Ensure every final pathology report includes a discrete microscopic description and a wet or electronic signature by the interpreting pathologist prior to billing. Cosigned reports require both signatures with clear role identification.

Denial: CLIA certificate missing or expired Medicare and most commercial payers reject claims when the laboratory's CLIA certificate number is missing, invalid, or expired. Prevention: Validate CLIA certificate status and expiration before each billing cycle. Ensure the CLIA number populates correctly in the billing system's laboratory fields.

Denial: Mohs surgery bundling A payer bundles 88305 into a same-day Mohs surgery claim, denying the pathology code as a component of the Mohs procedure. Prevention: Do not report 8830288309 for tissue examined as part of Mohs micrographic surgery. If the pathology service is for a different specimen on the same date as Mohs surgery, append -59 with documentation confirming the specimen is distinct from Mohs tissue [4].

Coding Scenarios

Scenario 1: Colonoscopy with multiple colon biopsies A gastroenterologist performs a colonoscopy and obtains biopsies from three separate colon sites (ascending, transverse, and sigmoid colon), each submitted in a separate labeled container. All three arrive in pathology on the same date.

Correct coding: 88305 × 3 units (append -59 or -XS on units 2 and 3 if payer edits fire)

Why: "Colon, biopsy" appears on the Level IV specimen list. Three distinct containers equal three units. Whether each biopsy reveals a hyperplastic polyp, tubular adenoma, or carcinoma does not change the level or unit count.

Scenario 2: Skin biopsy with melanoma — level question A dermatologist excises a pigmented lesion and the pathologist identifies malignant melanoma with negative margins. The billing team asks whether this escalates to Level V (88307) because cancer was found.

Correct coding: 88305 (not 88307)

Why: "Skin, other than cyst/tag/debridement/plastic repair" is on the Level IV specimen list. The pathological diagnosis of malignancy does not escalate the level. 88307 would apply if the specimen type appeared on the Level V list (e.g., breast excision requiring microscopic margin evaluation). Billing 88307 here based on the diagnosis is the textbook upcoding error flagged by OIG auditors [2].

Scenario 3: Frozen section followed by permanent section During a thyroid lobectomy, the surgeon requests intraoperative consultation. The pathologist freezes a section, communicates benign findings to the OR, then later reviews permanent sections and issues a final report of follicular adenoma.

Correct coding: 88331 (intraoperative consultation, first tissue block with frozen section) + 88305 (permanent section examination of same specimen)

Why: The frozen section service and the subsequent permanent section examination are distinct, separately reportable services. Frozen sections are not bundled with the permanent section pathology code.

Scenario 4: Hospital pathologist billing without modifier A pathology group contracted with a community hospital bills 88305 (no modifier) for all outpatient specimens. The hospital simultaneously bills 88305-TC.

Correct coding: Pathology group bills 88305-26; hospital bills 88305-TC (subject to OPPS packaging in the outpatient setting)

Why: The pathologists do not own the technical component — the hospital owns the lab, equipment, and personnel. Global billing by the group creates duplicate payment for the technical component. The -26/-TC split is required when the lab is facility-owned [1].

Related Codes

  • 88300: Level I, gross exam only; use when no microscopic examination is performed
  • 88302: Level II, gross and microscopic; lower-complexity specimens expected to be normal
  • 88304: Level III, gross and microscopic; moderate-low complexity specimen list
  • 88307: Level V, gross and microscopic; complex neoplastic resections requiring margin assessment
  • 88309: Level VI, gross and microscopic; most complex total organ resections
  • 88331: Intraoperative pathology consultation, first tissue block; separately reportable from 88305
  • 88332: Each additional tissue block, frozen section; add-on to 88331
  • 88342: Immunohistochemistry, initial single antibody; separately billable ancillary to 88305
  • 88341: Immunohistochemistry, each additional antibody; add-on to 88342
  • 88312: Special stain Group I (microorganism identification); separately billable with 88305
  • 88313: Special stain Group II (all other); separately billable with 88305
  • 0753T: Digital pathology slide scanning for Level IV; add-on to 88305

Sources

  1. CPT 88305 database record — CodingAhead CPT reference database, 2026. MUE, APC status, PC/TC indicator, global period, modifier frequency data.
  2. HHS OIG Work Plan — Anatomic Pathology — HHS Office of Inspector General — Compliance risk areas for anatomic pathology level assignment and upcoding.
  3. 42 CFR Part 493 — CLIA Regulations — eCFR/CMS — Laboratory certification requirements for high-complexity testing.
  4. AMA CPT Codebook, Surgical Pathology section (88300–88309) — American Medical Association — Official specimen lists, level definitions, and coding guidelines including Mohs exclusion.
  5. CMS Medicare Coverage Database — MAC LCD Search — CMS — MAC-level local coverage determinations for anatomic pathology by jurisdiction.

Related Codes

Official Description

Level IV - Surgical pathology, gross and microscopic examination

Abortion - spontaneous/missed
Artery, biopsy
Bone marrow, biopsy
Bone exostosis
Brain/meninges, other than for tumor resection
Breast, biopsy, not requiring microscopic evaluation of surgical margins
Breast, reduction mammoplasty
Bronchus, biopsy
Cell block, any source
Cervix, biopsy
Colon, biopsy
Duodenum, biopsy
Endocervix, curettings/biopsy
Endometrium, curettings/biopsy
Esophagus, biopsy
Extremity, amputation, traumatic
Fallopian tube, biopsy
Fallopian tube, ectopic pregnancy
Femoral head, fracture
Fingers/toes, amputation, non-traumatic
Gingiva/oral mucosa, biopsy
Heart valve
Joint, resection
Kidney, biopsy
Larynx, biopsy
Leiomyoma(s), uterine myomectomy - without uterus
Lip, biopsy/wedge resection
Lung, transbronchial biopsy
Lymph node, biopsy
Muscle, biopsy
Nasal mucosa, biopsy
Nasopharynx/oropharynx, biopsy
Nerve, biopsy
Odontogenic/dental cyst
Omentum, biopsy
Ovary with or without tube, non-neoplastic
Ovary, biopsy/wedge resection
Parathyroid gland
Peritoneum, biopsy
Pituitary tumor
Placenta, other than third trimester
Pleura/pericardium - biopsy/tissue
Polyp, cervical/endometrial
Polyp, colorectal
Polyp, stomach/small intestine
Prostate, needle biopsy
Prostate, TUR
Salivary gland, biopsy
Sinus, paranasal biopsy
Skin, other than cyst/tag/debridement/plastic repair
Small intestine, biopsy
Soft tissue, other than tumor/mass/lipoma/debridement
Spleen
Stomach, biopsy
Synovium
Testis, other than tumor/biopsy/castration
Thyroglossal duct/brachial cleft cyst
Tongue, biopsy
Tonsil, biopsy
Trachea, biopsy
Ureter, biopsy
Urethra, biopsy
Urinary bladder, biopsy
Uterus, with or without tubes and ovaries, for prolapse
Vagina, biopsy
Vulva/labia, biopsy

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 88305 refers to a Level IV surgical pathology examination, which involves both gross and microscopic evaluation of tissue specimens. This procedure is essential for diagnosing various conditions, particularly in cases where tissue is removed during surgical interventions such as biopsies, excisions, or resections. The process begins with the collection of tissue from the surgical site, which is then transported to a pathology laboratory for analysis. Upon receipt, the pathologist conducts a gross examination, visually inspecting the specimen to identify any notable characteristics that may indicate the presence of disease. Following this initial assessment, the specimen is prepared for microscopic examination, where the pathologist meticulously analyzes the cellular structure and composition of the tissue. This detailed examination aids in establishing a definitive diagnosis, determining the presence or absence of malignant neoplasms, and identifying the specific type of malignancy if one is present. Additionally, the pathologist evaluates the margins of the specimen to ascertain whether the entire diseased area has been excised. The findings from this comprehensive analysis are documented in a written report, which is subsequently shared with the treating physician to inform further clinical decision-making. Pathology services, including those reported under CPT® Code 88305, are categorized based on the type of tissue examined, the anticipated normalcy or pathology of the tissue, the complexity of the examination, and the time invested in the evaluation process.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The Level IV surgical pathology examination (CPT® Code 88305) is indicated for a variety of conditions and procedures where tissue analysis is necessary. The following are specific indications for performing this examination:

  • Abortion - spontaneous/missed Tissue examination may be required to assess the nature of the abortion.
  • Artery, biopsy Biopsy of arterial tissue to evaluate for pathological changes.
  • Bone marrow, biopsy Examination of bone marrow to diagnose hematological disorders.
  • Bone exostosis Evaluation of bone growths to determine their nature.
  • Brain/meninges, other than for tumor resection Analysis of brain or meninges tissue for various conditions.
  • Breast, biopsy, not requiring microscopic evaluation of surgical margins Assessment of breast tissue for abnormalities.
  • Breast, reduction mammoplasty Examination of tissue removed during breast reduction surgery.
  • Bronchus, biopsy Evaluation of bronchial tissue for respiratory conditions.
  • Cell block, any source Analysis of cellular material from various sources.
  • Cervix, biopsy Examination of cervical tissue to identify pathological changes.
  • Colon, biopsy Assessment of colon tissue for gastrointestinal disorders.
  • Duodenum, biopsy Evaluation of duodenal tissue for digestive issues.
  • Endocervix, curettings/biopsy Examination of endocervical tissue for abnormalities.
  • Endometrium, curettings/biopsy Analysis of endometrial tissue for uterine conditions.
  • Esophagus, biopsy Evaluation of esophageal tissue for various diseases.
  • Extremity, amputation, traumatic Examination of tissue from traumatic amputations.
  • Fallopian tube, biopsy Assessment of fallopian tube tissue for reproductive health issues.
  • Fallopian tube, ectopic pregnancy Analysis of tissue from ectopic pregnancies.
  • Femoral head, fracture Examination of femoral head tissue following a fracture.
  • Fingers/toes, amputation, non-traumatic Evaluation of tissue from non-traumatic amputations.
  • Gingiva/oral mucosa, biopsy Assessment of oral tissue for pathological conditions.
  • Heart valve Examination of heart valve tissue for disease.
  • Joint, resection Analysis of joint tissue following surgical resection.
  • Kidney, biopsy Evaluation of kidney tissue for renal disorders.
  • Larynx, biopsy Examination of laryngeal tissue for respiratory conditions.
  • Leiomyoma(s), uterine myomectomy - without uterus Assessment of uterine fibroids removed during surgery.
  • Lip, biopsy/wedge resection Evaluation of lip tissue for abnormalities.
  • Lung, transbronchial biopsy Examination of lung tissue obtained via bronchoscopy.
  • Lymph node, biopsy Assessment of lymph nodes for signs of disease.
  • Muscle, biopsy Evaluation of muscle tissue for various conditions.
  • Nasal mucosa, biopsy Examination of nasal tissue for pathological changes.
  • Nasopharynx/oropharynx, biopsy Assessment of tissue from the nasopharynx or oropharynx.
  • Nerve, biopsy Evaluation of nerve tissue for neurological disorders.
  • Odontogenic/dental cyst Examination of cystic lesions in dental tissues.
  • Omentum, biopsy Assessment of omental tissue for various conditions.
  • Ovary with or without tube, non-neoplastic Examination of ovarian tissue for non-cancerous conditions.
  • Ovary, biopsy/wedge resection Evaluation of ovarian tissue for abnormalities.
  • Parathyroid gland Examination of parathyroid tissue for disorders.
  • Peritoneum, biopsy Assessment of peritoneal tissue for pathological changes.
  • Pituitary tumor Examination of pituitary tissue for tumor analysis.
  • Placenta, other than third trimester Evaluation of placental tissue for abnormalities.
  • Pleura/pericardium - biopsy/tissue Assessment of pleural or pericardial tissue.
  • Polyp, cervical/endometrial Examination of cervical or endometrial polyps.
  • Polyp, colorectal Evaluation of colorectal polyps for pathology.
  • Polyp, stomach/small intestine Assessment of gastric or intestinal polyps.
  • Prostate, needle biopsy Examination of prostate tissue obtained via needle biopsy.
  • Prostate, TUR Evaluation of prostate tissue following transurethral resection.
  • Salivary gland, biopsy Assessment of salivary gland tissue for disease.
  • Sinus, paranasal biopsy Examination of paranasal sinus tissue.
  • Skin, other than cyst/tag/debridement/plastic repair Evaluation of skin tissue for various conditions.
  • Small intestine, biopsy Assessment of small intestinal tissue for pathology.
  • Soft tissue, other than tumor/mass/lipoma/debridement Examination of soft tissue for abnormalities.
  • Spleen Evaluation of splenic tissue for various conditions.
  • Stomach, biopsy Assessment of gastric tissue for pathology.
  • Synovium Examination of synovial tissue for joint disorders.
  • Testis, other than tumor/biopsy/castration Evaluation of testicular tissue for non-cancerous conditions.
  • Thyroglossal duct/brachial cleft cyst Examination of tissue from these cysts.
  • Tongue, biopsy Assessment of tongue tissue for abnormalities.
  • Tonsil, biopsy Examination of tonsillar tissue for disease.
  • Trachea, biopsy Evaluation of tracheal tissue for respiratory conditions.
  • Ureter, biopsy Assessment of ureteral tissue for pathology.
  • Urethra, biopsy Examination of urethral tissue for abnormalities.
  • Urinary bladder, biopsy Evaluation of bladder tissue for various conditions.
  • Uterus, with or without tubes and ovaries, for prolapse Examination of uterine tissue related to prolapse.
  • Vagina, biopsy Assessment of vaginal tissue for pathological changes.
  • Vulva/labia, biopsy Examination of vulvar or labial tissue for abnormalities.

2. Procedure

The procedure for a Level IV surgical pathology examination (CPT® Code 88305) involves several critical steps to ensure accurate diagnosis and evaluation of the tissue specimen. The following outlines the procedural steps:

  • Step 1: Specimen Collection The first step involves the collection of tissue during a surgical procedure, which may include biopsies, excisions, or resections. The tissue is carefully removed and placed in a suitable container to preserve its integrity during transport.
  • Step 2: Transport to Pathology Once collected, the specimen is transported from the surgical suite to the pathology laboratory. Proper handling and transport are crucial to prevent any degradation of the tissue that could affect the examination results.
  • Step 3: Gross Examination Upon arrival at the pathology lab, the pathologist conducts a gross examination of the specimen. This visual inspection allows the pathologist to note any defining characteristics, such as size, shape, color, and texture, which may provide initial insights into the nature of the tissue.
  • Step 4: Preparation for Microscopic Evaluation After the gross examination, the specimen is prepared for microscopic evaluation. This preparation may involve slicing the tissue into thin sections, fixing it in formalin, and embedding it in paraffin to create a stable sample for further analysis.
  • Step 5: Microscopic Analysis The pathologist then examines the prepared slides under a microscope. This detailed analysis focuses on the cellular structure and composition of the tissue, allowing the pathologist to identify any abnormalities, such as the presence of malignant neoplasms or other pathological conditions.
  • Step 6: Documentation of Findings Following the microscopic evaluation, the pathologist compiles a written report detailing the findings of the examination. This report includes information on the diagnosis, the presence or absence of malignancy, and an assessment of the surgical margins to determine if the entire diseased area was excised.
  • Step 7: Communication with Treating Physician Finally, a copy of the report is sent to the treating physician, providing them with essential information to guide further clinical decision-making and patient management.

3. Post-Procedure

After the Level IV surgical pathology examination is completed, the pathologist's findings are communicated to the treating physician, who will use this information to inform the patient's ongoing care. The report may indicate the need for further diagnostic testing, treatment options, or follow-up procedures based on the results of the tissue examination. It is essential for the treating physician to review the report thoroughly to understand the implications of the findings and to discuss them with the patient. Additionally, the pathologist may be available for consultation to clarify any aspects of the report or to provide further insights into the diagnosis. The patient may also require additional monitoring or interventions depending on the nature of the findings, particularly if malignancy is detected or if there are other significant pathological changes noted in the tissue.

Short Descr TISSUE EXAM BY PATHOLOGIST
Medium Descr LEVEL IV SURG PATHOLOGY GROSS&MICROSCOPIC EXAM
Long Descr Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgical margins Breast, reduction mammoplasty Bronchus, biopsy Cell block, any source Cervix, biopsy Colon, biopsy Duodenum, biopsy Endocervix, curettings/biopsy Endometrium, curettings/biopsy Esophagus, biopsy Extremity, amputation, traumatic Fallopian tube, biopsy Fallopian tube, ectopic pregnancy Femoral head, fracture Fingers/toes, amputation, non-traumatic Gingiva/oral mucosa, biopsy Heart valve Joint, resection Kidney, biopsy Larynx, biopsy Leiomyoma(s), uterine myomectomy - without uterus Lip, biopsy/wedge resection Lung, transbronchial biopsy Lymph node, biopsy Muscle, biopsy Nasal mucosa, biopsy Nasopharynx/oropharynx, biopsy Nerve, biopsy Odontogenic/dental cyst Omentum, biopsy Ovary with or without tube, non-neoplastic Ovary, biopsy/wedge resection Parathyroid gland Peritoneum, biopsy Pituitary tumor Placenta, other than third trimester Pleura/pericardium - biopsy/tissue Polyp, cervical/endometrial Polyp, colorectal Polyp, stomach/small intestine Prostate, needle biopsy Prostate, TUR Salivary gland, biopsy Sinus, paranasal biopsy Skin, other than cyst/tag/debridement/plastic repair Small intestine, biopsy Soft tissue, other than tumor/mass/lipoma/debridement Spleen Stomach, biopsy Synovium Testis, other than tumor/biopsy/castration Thyroglossal duct/brachial cleft cyst Tongue, biopsy Tonsil, biopsy Trachea, biopsy Ureter, biopsy Urethra, biopsy Urinary bladder, biopsy Uterus, with or without tubes and ovaries, for prolapse Vagina, biopsy Vulva/labia, biopsy
Status Code Active Code
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 1 - Diagnostic Tests for Radiology Services
Multiple Procedures (51) 0 - No payment adjustment rules for multiple procedures apply.
Bilateral Surgery (50) 0 - 150% payment adjustment for bilateral procedures does NOT apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 0 - Payment restriction for assistants at surgery applies to this procedure...
Co-Surgeons (62) 0 - Co-surgeons not permitted for this procedure.
Team Surgery (66) 0 - Team surgeons not permitted for this procedure.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator STV-Packaged Codes
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1G - Lab tests - other (Medicare fee schedule)
MUE 16
CCS Clinical Classification 234 - Pathology

This is a primary code that can be used with these additional add-on codes.

0753T Add-on Code MPFS Status: Carrier Priced APC N Digitization of glass microscope slides for level IV, surgical pathology, gross and microscopic examination (List separately in addition to code for primary procedure)
88311 Addon Code MPFS Status: Active Code APC N PUB 100 CPT Assistant Article Decalcification procedure (List separately in addition to code for surgical pathology examination)
88314 Addon Code MPFS Status: Active Code APC N PUB 100 CPT Assistant Article Special stain including interpretation and report; histochemical stain on frozen tissue block (List separately in addition to code for primary procedure)
26 Professional component: certain procedures are a combination of a physician or other qualified health care professional component and a technical component. when the physician or other qualified health care professional component is reported separately, the service may be identified by adding modifier 26 to the usual procedure number.
TC Technical component; under certain circumstances, a charge may be made for the technical component alone; under those circumstances the technical component charge is identified by adding modifier 'tc' to the usual procedure number; technical component charges are institutional charges and not billed separately by physicians; however, portable x-ray suppliers only bill for technical component and should utilize modifier tc; the charge data from portable x-ray suppliers will then be used to build customary and prevailing profiles
59 Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25.
GC This service has been performed in part by a resident under the direction of a teaching physician
X5 Diagnostic services requested by another clinician: for reporting services by a clinician who furnishes care to the patient only as requested by another clinician or subsequent and related services requested by another clinician; this modifier is reported for patient relationships that may not be adequately captured by the above alternative categories; reporting clinician service examples include but are not limited to, the radiologist's interpretation of an imaging study requested by another clinician
XS Separate structure, a service that is distinct because it was performed on a separate organ/structure
Q6 Service furnished under a fee-for-time compensation arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area
91 Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient.
AQ Physician providing a service in an unlisted health professional shortage area (hpsa)
76 Repeat procedure or service by same physician or other qualified health care professional: it may be necessary to indicate that a procedure or service was repeated by the same physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 76 to the repeated procedure or service. note: this modifier should not be appended to an e/m service.
XU Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service
XP Separate practitioner, a service that is distinct because it was performed by a different practitioner
XE Separate encounter, a service that is distinct because it occurred during a separate encounter
CR Catastrophe/disaster related
GW Service not related to the hospice patient's terminal condition
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
79 Unrelated procedure or service by the same physician or other qualified health care professional during the postoperative period: the individual may need to indicate that the performance of a procedure or service during the postoperative period was unrelated to the original procedure. this circumstance may be reported by using modifier 79. (for repeat procedures on the same day, see modifier 76.)
Q1 Routine clinical service provided in a clinical research study that is in an approved clinical research study
PT Colorectal cancer screening test; converted to diagnostic test or other procedure
77 Repeat procedure by another physician or other qualified health care professional: it may be necessary to indicate that a basic procedure or service was repeated by another physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 77 to the repeated procedure or service. note: this modifier should not be appended to an e/m service.
GA Waiver of liability statement issued as required by payer policy, individual case
GV Attending physician not employed or paid under arrangement by the patient's hospice provider
22 Increased procedural services: when the work required to provide a service is substantially greater than typically required, it may be identified by adding modifier 22 to the usual procedure code. documentation must support the substantial additional work and the reason for the additional work (ie, increased intensity, time, technical difficulty of procedure, severity of patient's condition, physical and mental effort required). note: this modifier should not be appended to an e/m service.
25 Significant, separately identifiable evaluation and management service by the same physician or other qualified health care professional on the same day of the procedure or other service: it may be necessary to indicate that on the day a procedure or service identified by a cpt code was performed, the patient's condition required a significant, separately identifiable e/m service above and beyond the other service provided or beyond the usual preoperative and postoperative care associated with the procedure that was performed. a significant, separately identifiable e/m service is defined or substantiated by documentation that satisfies the relevant criteria for the respective e/m service to be reported (see evaluation and management services guidelines for instructions on determining level of e/m service). the e/m service may be prompted by the symptom or condition for which the procedure and/or service was provided. as such, different diagnoses are not required for reporting of the e/m services on the same date. this circumstance may be reported by adding modifier 25 to the appropriate level of e/m service. note: this modifier is not used to report an e/m service that resulted in a decision to perform surgery. see modifier 57 for significant, separately identifiable non-e/m services, see modifier 59.
27 Multiple outpatient hospital e/m encounters on the same date: for hospital outpatient reporting purposes, utilization of hospital resources related to separate and distinct e/m encounters performed in multiple outpatient hospital settings on the same date may be reported by adding modifier 27 to each appropriate level outpatient and/or emergency department e/m code(s). this modifier provides a means of reporting circumstances involving evaluation and management services provided by physician(s) in more than one (multiple) outpatient hospital setting(s) (eg, hospital emergency department, clinic). note: this modifier is not to be used for physician reporting of multiple e/m services performed by the same physician on the same date. for physician reporting of all outpatient evaluation and management services provided by the same physician on the same date and performed in multiple outpatient setting(s) (eg, hospital emergency department, clinic), see evaluation and management, emergency department, or preventive medicine services codes.
32 Mandated services: services related to mandated consultation and/or related services (eg, third party payer, governmental, legislative or regulatory requirement) may be identified by adding modifier 32 to the basic procedure.
33 Preventive services: when the primary purpose of the service is the delivery of an evidence based service in accordance with a us preventive services task force a or b rating in effect and other preventive services identified in preventive services mandates (legislative or regulatory), the service may be identified by adding 33 to the procedure. for separately reported services specifically identified as preventive, the modifier should not be used.
51 Multiple procedures: when multiple procedures, other than e/m services, physical medicine and rehabilitation services or provision of supplies (eg, vaccines), are performed at the same session by the same individual, the primary procedure or service may be reported as listed. the additional procedure(s) or service(s) may be identified by appending modifier 51 to the additional procedure or service code(s). note: this modifier should not be appended to designated "add-on" codes (see appendix d).
52 Reduced services: under certain circumstances a service or procedure is partially reduced or eliminated at the discretion of the physician or other qualified health care professional. under these circumstances the service provided can be identified by its usual procedure number and the addition of modifier 52, signifying that the service is reduced. this provides a means of reporting reduced services without disturbing the identification of the basic service. note: for hospital outpatient reporting of a previously scheduled procedure/service that is partially reduced or cancelled as a result of extenuating circumstances or those that threaten the well-being of the patient prior to or after administration of anesthesia, see modifiers 73 and 74 (see modifiers approved for asc hospital outpatient use).
56 Preoperative management only: when 1 physician or other qualified health care professional performed the preoperative care and evaluation and another performed the surgical procedure, the preoperative component may be identified by adding modifier 56 to the usual procedure number.
58 Staged or related procedure or service by the same physician or other qualified health care professional during the postoperative period: it may be necessary to indicate that the performance of a procedure or service during the postoperative period was: (a) planned or anticipated (staged); (b) more extensive than the original procedure; or (c) for therapy following a surgical procedure. this circumstance may be reported by adding modifier 58 to the staged or related procedure. note: for treatment of a problem that requires a return to the operating/procedure room (eg, unanticipated clinical condition), see modifier 78.
62 Two surgeons: when 2 surgeons work together as primary surgeons performing distinct part(s) of a procedure, each surgeon should report his/her distinct operative work by adding modifier 62 to the procedure code and any associated add-on code(s) for that procedure as long as both surgeons continue to work together as primary surgeons. each surgeon should report the co-surgery once using the same procedure code. if additional procedure(s) (including add-on procedure(s) are performed during the same surgical session, separate code(s) may also be reported with modifier 62 added. note: if a co-surgeon acts as an assistant in the performance of additional procedure(s), other than those reported with the modifier 62, during the same surgical session, those services may be reported using separate procedure code(s) with modifier 80 or modifier 82 added, as appropriate.
78 Unplanned return to the operating/procedure room by the same physician or other qualified health care professional following initial procedure for a related procedure during the postoperative period: it may be necessary to indicate that another procedure was performed during the postoperative period of the initial procedure (unplanned procedure following initial procedure). when this procedure is related to the first, and requires the use of an operating/procedure room, it may be reported by adding modifier 78 to the related procedure. (for repeat procedures, see modifier 76.)
95 Synchronous telemedicine service rendered via a real-time interactive audio and video telecommunications system: synchronous telemedicine service is defined as a real-time interaction between a physician or other qualified health care professional and a patient who is located at a distant site from the physician or other qualified health care professional. the totality of the communication of information exchanged between the physician or other qualified health care professional and the patient during the course of the synchronous telemedicine service must be of an amount and nature that would be sufficient to meet the key components and/or requirements of the same service when rendered via a face-to-face interaction. modifier 95 may only be appended to the services listed in appendix p. appendix p is the list of cpt codes for services that are typically performed face-to-face, but may be rendered via a real-time (synchronous) interactive audio and video telecommunications system.
99 Multiple modifiers: under certain circumstances 2 or more modifiers may be necessary to completely delineate a service. in such situations modifier 99 should be added to the basic procedure, and other applicable modifiers may be listed as part of the description of the service.
AF Specialty physician
AY Item or service furnished to an esrd patient that is not for the treatment of esrd
CC Procedure code change (use 'cc' when the procedure code submitted was changed either for administrative reasons or because an incorrect code was filed)
FP Service provided as part of family planning program
GE This service has been performed by a resident without the presence of a teaching physician under the primary care exception
GX Notice of liability issued, voluntary under payer policy
GY Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit
GZ Item or service expected to be denied as not reasonable and necessary
KX Requirements specified in the medical policy have been met
LT Left side (used to identify procedures performed on the left side of the body)
PC Wrong surgery or other invasive procedure on patient
PD Diagnostic or related non diagnostic item or service provided in a wholly owned or operated entity to a patient who is admitted as an inpatient within 3 days
PO Excepted service provided at an off-campus, outpatient, provider-based department of a hospital
Q0 Investigational clinical service provided in a clinical research study that is in an approved clinical research study
Q2 Demonstration procedure/service
Q3 Live kidney donor surgery and related services
Q5 Service furnished under a reciprocal billing arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area
QJ Services/items provided to a prisoner or patient in state or local custody, however the state or local government, as applicable, meets the requirements in 42 cfr 411.4 (b)
QW Clia waived test
RT Right side (used to identify procedures performed on the right side of the body)
SA Nurse practitioner rendering service in collaboration with a physician
ST Related to trauma or injury
T1 Left foot, second digit
T2 Left foot, third digit
T4 Left foot, fifth digit
T5 Right foot, great toe
T6 Right foot, second digit
T8 Right foot, fourth digit
T9 Right foot, fifth digit
TA Left foot, great toe
TD Rn
TF Intermediate level of care
TG Complex/high tech level of care
TT Individualized service provided to more than one patient in same setting
TV Special payment rates, holidays/weekends
U6 Medicaid level of care 6, as defined by each state
UD Medicaid level of care 13, as defined by each state
X1 Continuous/broad services: for reporting services by clinicians, who provide the principal care for a patient, with no planned endpoint of the relationship; services in this category represent comprehensive care, dealing with the entire scope of patient problems, either directly or in a care coordination role; reporting clinician service examples include, but are not limited to: primary care, and clinicians providing comprehensive care to patients in addition to specialty care
X2 Continuous/focused services: for reporting services by clinicians whose expertise is needed for the ongoing management of a chronic disease or a condition that needs to be managed and followed with no planned endpoint to the relationship; reporting clinician service examples include but are not limited to: a rheumatologist taking care of the patient's rheumatoid arthritis longitudinally but not providing general primary care services
X3 Episodic/broad services: for reporting services by clinicians who have broad responsibility for the comprehensive needs of the patient that is limited to a defined period and circumstance such as a hospitalization; reporting clinician service examples include but are not limited to the hospitalist's services rendered providing comprehensive and general care to a patient while admitted to the hospital
X4 Episodic/focused services: for reporting services by clinicians who provide focused care on particular types of treatment limited to a defined period and circumstance; the patient has a problem, acute or chronic, that will be treated with surgery, radiation, or some other type of generally time-limited intervention; reporting clinician service examples include but are not limited to, the orthopedic surgeon performing a knee replacement and seeing the patient through the postoperative period
Date
Action
Notes
2013-01-01 Changed Description Changed
2009-01-01 Changed Code description changed.
2007-01-01 Changed Code description changed.
2002-01-01 Changed Code description changed.
Pre-1990 Added Code added.
Code
Description
Code
Description
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"